Cargando…

Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver disorder worldwide. The pathological spectrum of NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) that induces progressive liver cirrhosis and eventually hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Juqiang, Zhang, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358116/ https://www.ncbi.nlm.nih.gov/pubmed/34395461 http://dx.doi.org/10.3389/fmed.2021.653293

Ejemplares similares

Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Holzner, Lorenz M. W., et al.
Publicado: (2021)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver
por: Pang, Qiwen, et al.
Publicado: (2020)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
por: Heyens, Leen J. M., et al.
Publicado: (2021)

Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease
por: Amir, Muhammad, et al.
Publicado: (2020)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Pathogenesis of non-alcoholic fatty liver disease
por: Dowman, J. K., et al.
Publicado: (2010)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
por: Xiao, Jieling, et al.
Publicado: (2021)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022)

Complement Component C3 Participates in Early Stages of Niemann–Pick C Mouse Liver Damage
por: Klein, Andrés D., et al.
Publicado: (2020)

Serum Complement C3f and Fibrinopeptide A Are Potential Novel Diagnostic Biomarkers for Non-Alcoholic Fatty Liver Disease: A Study in Qingdao Twins
por: Xin, Yong-Ning, et al.
Publicado: (2014)

Knowing What’s Out There: Awareness of Non-Alcoholic Fatty Liver Disease
por: Ghevariya, Vishal, et al.
Publicado: (2014)

Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
por: Ng, Cheng Han, et al.
Publicado: (2022)

The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease
por: Li, Jiawei, et al.
Publicado: (2016)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Key Events Participating in the Pathogenesis of Alcoholic Liver Disease
por: Magdaleno, Fernando, et al.
Publicado: (2017)

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
por: Delli Bovi, Anna Pia, et al.
Publicado: (2021)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021)

Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)

Pathogenesis of Alcoholic Fatty Liver a Narrative Review
por: Seitz, Helmut K., et al.
Publicado: (2023)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
por: Li, Na, et al.
Publicado: (2021)

Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
por: Santacroce, Giovanni, et al.
Publicado: (2023)

Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease
por: Li, Xiaoyan, et al.
Publicado: (2020)

Pathogenesis and Therapeutic Strategies Related to Non-Alcoholic Fatty Liver Disease
por: Teng, Tieshan, et al.
Publicado: (2022)

Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
por: Ma, Dae Won, et al.
Publicado: (2023)

Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Han, Liu, et al.
Publicado: (2022)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review
por: Slouha, Ethan, et al.
Publicado: (2023)

Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
por: Choi, Ji Min, et al.
Publicado: (2022)

Non-alcoholic Fatty Liver Disease and Longitudinal Cognitive Changes in Middle-Aged and Elderly Adults
por: Liu, Qi, et al.
Publicado: (2022)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
por: Baffy, György
Publicado: (2013)

Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack
por: Oates, Jarren R., et al.
Publicado: (2019)

The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
por: Jennison, Erica, et al.
Publicado: (2021)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4gsip283fs2h06omk7o11bb2vu